Laurie Hare-Duke writes his debut elf blog on a recent meta-analysis on loneliness and the psychosis continuum, which finds that loneliness is associated with both positive and negative psychotic symptoms, and is more strongly associated with paranoia than with hallucinations.[read the full story...]
The Trial: pharmacotherapy versus psychotherapy for schizophrenia – how do trials compare?
Keith Laws looks at a systematic review of patient and study characteristics, which asks: are randomised controlled trials on pharmacotherapy and psychotherapy for positive symptoms of schizophrenia comparable?[read the full story...]
Is Cannabidiol (CBD) an effective antipsychotic?
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.[read the full story...]
Sameer Jauhar and Paul Morrison consider the revised Understanding Psychosis and Schizophrenia report from the British Psychological Society Division of Clinical Psychology, which includes updated sections on definitions, aetiology and treatment.[read the full story...]
Cannabis and psychosis: it’s high time for a review
Joe Barnby considers the findings of a recent meta-analysis of cannabis use and symptoms severity in individuals at ultra-high risk for psychosis.[read the full story...]
Adding antidepressants to antipsychotics in schizophrenia: do they work, for what, and are they safe?
Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.[read the full story...]
Outcomes in first episode manic psychosis
Matthew Broome writes his debut Mental Elf blog on a three-year clinical and functional outcome comparison between first episode manic psychosis and first-episode schizophrenia.[read the full story...]
Transcranial magnetic stimulation for schizophrenia
Joanne Wallace considers the findings of a new Cochrane systematic review on Transcranial Magnetic Stimulation (TMS) for schizophrenia.[read the full story...]
Diagnostic test accuracy of first rank symptoms for schizophrenia
Raphael Underwood summarises a recently updated Cochrane systematic review, which aimed to systematically evaluate the accuracy of first rank symptoms for diagnosing schizophrenia.[read the full story...]
Exercise for severe mental illness: new review finds few benefits
This new systematic review concludes that exercise programmes can lead to an improvement in exercise activity, but have no significant effect on mental health symptoms or body weight in people with severe mental illness.[read the full story...]